Anticoagulant heparan sulfate: structural specificity and biosynthesis

被引:108
作者
Liu, Jian
Pedersen, Lars C.
机构
[1] Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
[2] Natl Inst Environm Hlth Sci, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA
关键词
heparin; heparan sulfate; sulfotransferase; anticoagulant; oligosaccharide; herpes simplex virus;
D O I
10.1007/s00253-006-0722-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Heparan sulfate (HS) is present on the surface of endothelial and surrounding tissues in large quantities. It plays important roles in regulating numerous functions of the blood vessel wall, including blood coagulation, inflammation response, and cell differentiation. HS is a highly sulfated polysaccharide containing glucosamine and glucuronic/iduronic acid repeating disaccharide units. The unique sulfated saccharide sequences of HS determine its specific functions. Heparin, an analog of HS, is the most commonly used anticoagulant drug. Because of its wide range of biological functions, HS has become an interesting molecule to biochemists, medicinal chemists, and developmental biologists. In this review, we summarize recent progress toward understanding the interaction between HS and blood- coagulating factors, the biosynthesis of anticoagulant HS and the mechanism of action of HS biosynthetic enzymes. Furthermore, knowledge of the biosynthesis of HS facilitates the development of novel enzymatic approaches to synthesize HS from bacterial capsular polysaccharides and to produce polysaccharide end products with high specificity for the biological target. These advancements provide the foundation for the development of polysaccharide-based therapeutic agents.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 62 条
[1]   Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase -: Structure and activity of the fourth member, NDST4 [J].
Aikawa, J ;
Grobe, K ;
Tsujimoto, M ;
Esko, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) :5876-5882
[2]   Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library [J].
Ashikari-Hada, S ;
Habuchi, H ;
Kariya, Y ;
Itoh, N ;
Reddi, AH ;
Kimata, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12346-12354
[3]   CONTRIBUTION OF MONOSACCHARIDE RESIDUES IN HEPARIN BINDING TO ANTITHROMBIN-III [J].
ATHA, DH ;
LORMEAU, JC ;
PETITOU, M ;
ROSENBERG, RD ;
CHOAY, J .
BIOCHEMISTRY, 1985, 24 (23) :6723-6729
[4]   Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties [J].
Avci, FY ;
Karst, NA ;
Linhardt, RJ .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (28) :2323-2335
[5]   Optimizing heparin compounds: A working construct for future antithrombotic drug development [J].
Becker, RC .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2004, 18 (01) :55-58
[6]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[7]   Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides [J].
Burkart, MD ;
Izumi, M ;
Chapman, E ;
Lin, CH ;
Wong, CH .
JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (18) :5565-5574
[8]   Enzymatic redesigning of biologically active heparan sulfate [J].
Chen, JH ;
Avci, FY ;
Muñoz, EM ;
McDowell, LM ;
Chen, M ;
Pedersen, LC ;
Zhang, LJ ;
Linhardt, RJ ;
Liu, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) :42817-42825
[9]   Biosynthesis of 3-O-sulfated heparan sulfate:: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5 [J].
Chen, JH ;
Duncan, MB ;
Carrick, K ;
Pope, RM ;
Liu, J .
GLYCOBIOLOGY, 2003, 13 (11) :785-794
[10]   Heparan sulfate-protein interactions: therapeutic potential through structure-function insights [J].
Coombe, DR ;
Kett, WC .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (04) :410-424